Pills masthead

Fundamentals

Select the financial statements you wish to view below.  The reports below may be viewed on either an annual or quarterly basis.

NYSELCI
All numbers in thousands USD
Period Ending
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Total Revenue
80,894
75,079
74,189
78,357
Cost of Revenue
66,616
62,480
66,332
75,279
Gross Profit
14,278
12,599
7,857
3,078
Operating Expenses
Research Development
4,928
7,179
6,044
5,807
Selling General and Administrative
18,317
16,697
25,755
17,572
Non Recurring
--
--
--
--
Others
0
0
0
0
Total Operating Expenses
23,245
23,876
31,799
23,379
Operating Income or Loss
(8,967)
(11,277)
(23,942)
(20,301)
Income from Continuing Operations
Total Other Income/Expenses Net
(12,125)
(1,678)
(54,058)
(1,445)
Earnings Before Interest And Taxes
(21,092)
(12,955)
(78,000)
(21,746)
Interest Expense
15,184
15,030
14,808
14,517
Income Before Tax
(36,276)
(27,985)
(92,808)
(36,263)
Income Tax Expense
32
34
487
(1,365)
Minority Interest
--
--
--
--
Net Income From Continuing Ops
(36,308)
(28,019)
(93,295)
(34,898)
Non-recurring Events
Discontinued Operations
--
--
--
--
Extraordinary Items
--
--
--
--
Effect Of Accounting Changes
--
--
--
--
Other Items
0
0
0
0
Net Income
(36,308)
(28,019)
(93,295)
(34,898)
Preferred Stock And Other Adjustments
--
--
--
--
Net Income Applicable To Common Shares
(36,308)
(28,019)
(93,295)
(34,898)